About
Coric earned a B.S. from the University of Connecticut and an M.D. from Wake Forest University School of Medicine, then completed an internship, residency and fellowship at Yale. He has been an associate clinical professor of psychiatry at Yale School of Medicine since July 2001. From January 2007 to September 2015 he was a group director of global clinical research at Bristol-Myers Squibb. He was then CEO of the former Biohaven parent company from 2015 until the 2022 separation that created today's Biohaven. Other biotech chief executives with pages on Whoo include Kyle Gano of Neurocrine Biosciences and Joseph Belanoff of Corcept Therapeutics.
Whoo compiled this page from public sources: Biohaven 2026 proxy statement (SEC), Biohaven Q3 2026 results release (SEC), Biohaven Form 10-K, 2025 (SEC). It is not affiliated with or endorsed by Vlad Coric. Are you Vlad Coric? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chairman and Chief Executive Officer — Biohaven Ltd.
2022 – Present | New Haven, Connecticut
- CEO and director since the company formed; Board chair since September 28, 2022
Chief Executive Officer — Former Biohaven parent company
2015 – 2022
Group Director, Global Clinical Research — Bristol-Myers Squibb
January 2007 – September 2015
Associate Clinical Professor of Psychiatry — Yale School of Medicine
July 2001 – Present